Advertisement
Canada markets open in 5 hours 27 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7272
    +0.0008 (+0.11%)
     
  • CRUDE OIL

    83.66
    +0.93 (+1.12%)
     
  • Bitcoin CAD

    88,922.97
    +4,694.82 (+5.57%)
     
  • CMC Crypto 200

    1,327.69
    +15.06 (+1.15%)
     
  • GOLD FUTURES

    2,402.40
    +4.40 (+0.18%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,428.00
    -119.25 (-0.68%)
     
  • VOLATILITY

    20.71
    +2.71 (+15.06%)
     
  • FTSE

    7,829.55
    -47.50 (-0.60%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Why Shares of Krystal Biotech Are Rising Monday

Why Shares of Krystal Biotech Are Rising Monday

Shares of Krystal Biotech (NASDAQ: KRYS) were up more than 15% Monday morning. The company announced on Friday that it had received Food and Drug Administration (FDA) approval for Vyjuvek (beremagene geperpavec-svdt) as the first therapy to treat dystrophic epidermolysis bullosa (DEB), known as "butterfly skin," at the genetic level. The rare disease weakens the skin, causes it to blister easily and leading to a greater incidence of injuries.